Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
illa ao tngt o tnenrgaude apea hntm nhitfsSdl rs arisntdhte nstctm oealrs tgAmn.lsw igboeih r ohonoshb Uecccitnasnai rh., be wreeeiieu euj neo ehetu dddt.yaanmrueyihT tarersstlt h endgesatt pcoi wpdfmme vdii osn oiptt iDlrncruitoFin
snnoae bidtstttenaglreesdtrlea o euno dn i uioesdail anrfvsttdorcp vFh tsi yt oheheerfro p.ew hiti ri fbueleaihnow asognTrai dthAph uetoe mkDlt2u rts0ytgmTa ee. trptTlditnb0inpekiercepae c ol li etdanoiasd mutvercety saamtfrce,oetr
dnsle s isae i oeoel at i ynwegeyMtuorfitwdmew”oWgwhe’ikDtie,gn“ e osAsrm lsohv he kBwSwadiC i nre aleaiads ettrnWm ya tsiD nvh icaetha betoteran itti saenr.sMeThtl mFmaiWrini o vr dlneorWtto
fedo wratfs md , ’ae tnce iawutpmnnone vak eaton inrfodlTime hmecaeMaelrr ’m iylgted spa n tya ci tcorie dimghi nrocoeye itcounaisdsuBaarsp rweargdt ssa a ehka efshvnhenpna ltru ivch ht oyg iealirddttaesrei niwslmlr sinerparcnit ahtl csieah ipemceetntd,cat iha mrire ktcinygaa pel eee .sr nFeotiisineioho e r nuoyoiooays httcnniitgl.
ndfie,hoacitbleiu” n ssp er ’ns h tyrp stprahdhaoseortr”oluitcel eNfu tldw“.emsrehtsoo ees.es nwet p eiecto,ubc“r olipd Tt ihliiep sole ohnaasbnr
r nceah Aassterguoon e, mfehngaja v ehr hdmsennii.ht sr neviaystrtdpkgersee o oaga oeD erni ctstiuuo tssnersIsaenm t Fteagohe tkegsaicdeoth an tlllmct ecra t’s
giakiensahormn nKro“ so ivt stneioee cio, tho-lahs sc “ amtTieh ucfi onr lgofs irsatbwibt ’tsmc,nril espsrtssacpbee ansanHahird rlsig iKit gi feva vedipf hrouCeahaeeed mstW ,tr bahfi fbaptresilositadaCe g ”e r a”asreo..n
nlaaot2si lue ricudnatp.yactaey nefy raltn nr ieCe t, nm w ecaograva ep auumytlr hrmeoait c eiJeeWdaeytson .esdhbAencofastndte nth a ur uByc n f iugndoep%ynteher mt lmeatsttditsnatirfdi gtgs0isan aAessan i’dgfoois e ondo5e’t7eetdmcn’foj Mo rikueerires ys ctthsb geouenuud tcy ctjem nidiaatrefDd ne ea asr1eo c hlnksefee hof tFntmoc 1h i flsah.ht tt s hep sefra,usrsso
tpu feotnrerar fencit ortsna tn opthoefnneru dae tpttabmein Gllesdotrolh el,rmse hystn rd nurrti,ti utdo rniniDafe.etdarneeicT’t rwaatioeFyD ele n c ew esaPeetbn oeotte oduc mr.dlebehdaHofcer’ oSbia gimorsvAtrmodent emmnhsr dt ttrs sa iee d fdv e tcoirbuefpflitfggorde hsu in tojraosyiag tme
atoeayv l tw.oyt a daiulpessle r es usep ghD lA gottn prtvtuatrtnd tehnmydersant sbeFmct nesaracdoohuee eaws btes oikrn ge ddtaadharr a rt’h Motheatleboiens areiceool
taeetadeed”gasr Wy eass nistte toeraraa jaetay c hdl.n ne iv f tineu“a onacphgt’ nh t, eteb lrprrs r illd
“rabah.t eMenafel e wet jwarhAetcalksduiteFe.ioe g y ihasbaasa HJelaicivne gn pr psayce ’nf ciuur tciRtmaddhhnhdrt bKgn b ne rii t s b ofotppaFm edr dlly”ed otekrS ynenHusia e rt.Sepyrdcrnnsre eysrrotTeaa n D
Please enable JavaScript to view this content.
This isn’t the whole story. First, these letters are only for drugs that were approved eventually. And second, there are only two that hadn’t been made public before as part of the FDA review documents.
In other words…a nothingburger.